OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Astrazeneca PLC ORD SHS $0.25/  GB0009895292  /

London Domestic
9/22/2023  5:54:22 PM Chg. +160.0 Volume Bid6:00:08 AM Ask6:00:08 AM Market Capitalization Dividend Y. P/E Ratio
11,046.0GBX +1.47% 3.55 mill.
Turnover(GBP): 266.04 mill.		 11,000.0Bid Size: 40 11,200.0Ask Size: 30 171.15 bill.GBP - -
TeleTrader 7/28 AstraZeneca's Q2 revenue rises 6% to $11.42B
TeleTrader 7/17 AstraZeneca-Sanofi RSV shot for children approved by FDA
TeleTrader 4/27 AstraZeneca's Q1 revenue down by 4% to $10.88B
TeleTrader 2/9 AstraZeneca's Q4 revenue down by 7% to $11.21B
TeleTrader 1/27 FDA halts use of Evusheld due to low effectiveness
TeleTrader 1/13 AstraZeneca signs COVID treatment deal with China
TeleTrader 11/29/2022 AstraZeneca to acquire Neogene for $320M
TeleTrader 11/10/2022 AstraZeneca's Q3 revenue soars 11% to $10.9B
TeleTrader 11/3/2022 AstraZeneca user error exposed patient data - report
TeleTrader 7/29/2022 AstraZeneca's Q2 revenue up 31% to $10.8B
TeleTrader 7/5/2022 AstraZeneca to acquire TeneoTwo for $1.27 billion
TeleTrader 5/24/2022 AstraZeneca, Samsung Biologics shut down joint venture - report
TeleTrader 4/29/2022 AstraZeneca's Q1 core EPS rises 16% to $1.89
TeleTrader 4/14/2022 Canada approves AstraZeneca's Evusheld
TeleTrader 3/24/2022 EMA backs AstraZeneca's COVID drug for prevention
TeleTrader 3/17/2022 AstraZeneca may give up seeking US jab approval
GlobeNewswire 3/7/2022 HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for ...
GlobeNewswire 3/3/2022 HUTCHMED Reports 2021 Full Year Results and Provides Business Updates
GlobeNewswire 3/3/2022 Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
GlobeNewswire 2/10/2022 AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022
TeleTrader 2/10/2022 AstraZeneca's Q4 revenue soars 62% to $12.01B
TeleTrader 1/13/2022 AstraZeneca's Vaxzevria boosts response against Omicron - study
GlobeNewswire 1/5/2022 Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca
GlobeNewswire 1/3/2022 Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators
TeleTrader 12/27/2021 Israel changes advice on booster timeline